Form D — Phio Pharmaceuticals Corp.
0001123292-25-000633 · filed 2025-11-12
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $25,931,342
- Total sold
- $1,415,796
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Phio Pharmaceuticals Corp.
- CIK
- 1533040
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 411 SWEDELAND ROAD
KING OF PRUSSIA, PA 19406 - Phone
- 760-943-1088
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Robert J. Bitterman · DirectorKing of Prussia, PA Find on LinkedIn ↗
-
Patricia A. Bradford · DirectorKing of Prussia, PA Find on LinkedIn ↗
-
Jonathan Freeman · DirectorKing of Prussia, PA Find on LinkedIn ↗
-
Curtis Lockshin, Ph.D. · DirectorKing of Prussia, PA Find on LinkedIn ↗
-
David H. Deming · DirectorKing of Prussia, PA Find on LinkedIn ↗
-
Lisa Carson · Executive OfficerKing of Prussia, PA Find on LinkedIn ↗
View original on SEC EDGAR.